• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2(COX-2)在马黑素细胞肿瘤中的表达

Cyclooxygenase-2 (COX-2) Expression in Equine Melanocytic Tumors.

作者信息

Pimenta José, Prada Justina, Pires Isabel, Cotovio Mário

机构信息

CECAV-Veterinary and Animal Research Center, University of Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal.

Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal.

出版信息

Vet Sci. 2024 Feb 7;11(2):77. doi: 10.3390/vetsci11020077.

DOI:10.3390/vetsci11020077
PMID:38393095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10891553/
Abstract

Equine melanocytic tumors are common and have an unusual benign behavior with low invasiveness and metastatic rates. However, tumoral mass growth is usually a concern that can have life-threatening consequences. COX-2 is related to oncogenesis, promoting neoplastic cell proliferation, invasion, and metastasis. The aim of this study was to evaluate the immunohistochemical expression of COX-2 in equine melanocytic tumors. Through extension and intensity of labeling, 39 melanocytomas and 38 melanomas were evaluated. Of the malignant tumors, 13.2% were negative and 63.2% presented a low COX-2 expression. Only 6 malignant tumors presented >50% of labeled cells, 18 malignant and 8 benign had an expression between 21 and 50%, 8 malignant and 3 benign tumors had an expression between 6 and 20%, 1 malignant tumor had an expression between 1 and 5%, and 5 malignant and 28 benign tumors had no expression. Malignant tumors showed higher COX-2 expression than did benign tumors, with statistically significant differences. The low levels of COX-2 may be one of the molecular reasons for the presence of expansive mass growth instead of the invasive pattern of other species, which is related to high COX-2 levels.

摘要

马黑素细胞瘤很常见,具有不寻常的良性行为,侵袭性和转移率较低。然而,肿瘤块的生长通常是一个令人担忧的问题,可能会产生危及生命的后果。COX-2与肿瘤发生有关,可促进肿瘤细胞的增殖、侵袭和转移。本研究的目的是评估COX-2在马黑素细胞瘤中的免疫组化表达。通过标记的范围和强度,对39例黑素细胞瘤和38例黑色素瘤进行了评估。在恶性肿瘤中,13.2%为阴性,63.2%表现为低COX-2表达。只有6例恶性肿瘤的标记细胞>50%,18例恶性和8例良性肿瘤的表达在21%至50%之间,8例恶性和3例良性肿瘤的表达在6%至20%之间,1例恶性肿瘤的表达在1%至5%之间,5例恶性和28例良性肿瘤无表达。恶性肿瘤的COX-2表达高于良性肿瘤,差异有统计学意义。COX-2水平低可能是马黑素细胞瘤出现膨胀性肿块生长而非其他物种侵袭性模式的分子原因之一,其他物种的侵袭性模式与高COX-2水平有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20c/10891553/b0911d3c522b/vetsci-11-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20c/10891553/b0911d3c522b/vetsci-11-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20c/10891553/b0911d3c522b/vetsci-11-00077-g001.jpg

相似文献

1
Cyclooxygenase-2 (COX-2) Expression in Equine Melanocytic Tumors.环氧化酶-2(COX-2)在马黑素细胞肿瘤中的表达
Vet Sci. 2024 Feb 7;11(2):77. doi: 10.3390/vetsci11020077.
2
E-Cadherin Immunostaining in Equine Melanocytic Tumors.马黑素细胞肿瘤中的E-钙黏蛋白免疫染色
Animals (Basel). 2023 Jul 6;13(13):2216. doi: 10.3390/ani13132216.
3
Programmed Cell Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Equine Melanocytic Tumors.程序性细胞死亡配体1(PD-L1)在马黑素细胞肿瘤中的免疫组织化学表达
Animals (Basel). 2023 Dec 22;14(1):48. doi: 10.3390/ani14010048.
4
Study of c-kit immunoexpression in canine cutaneous melanocytic tumors.犬皮肤黑色素细胞瘤中 c-kit 免疫表达的研究。
Melanoma Res. 2012 Jun;22(3):195-201. doi: 10.1097/CMR.0b013e32835273f9.
5
Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.免疫组织化学分析 S100A1、S100B、CD44 和 Bcl-2 抗原以及 Ki-67 抗体评估的细胞增殖率在良性和恶性黑色素瘤肿瘤中的表达。
Melanoma Res. 2010 Apr;20(2):118-25. doi: 10.1097/CMR.0b013e3283350554.
6
Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours.研究犬黑素细胞瘤中环氧合酶-2表达与血管生成、增殖、巨噬细胞及T淋巴细胞浸润的相关性。
Melanoma Res. 2016 Aug;26(4):338-47. doi: 10.1097/CMR.0000000000000262.
7
S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.黑色素细胞肿瘤中的S-100蛋白。对良性和恶性黑色素细胞肿瘤以及恶性黑色素瘤转移灶的免疫组织化学研究,并与人类大脑相比对抗原进行表征。
Acta Pathol Microbiol Immunol Scand A. 1984 Jul;92(4):219-30.
8
[Evaluation of COX-2 protein expression in melanocytic nevi in children].[儿童黑素细胞痣中COX-2蛋白表达的评估]
Pol Merkur Lekarski. 2013 Aug;35(206):82-4.
9
Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.环氧化酶-2在犬葡萄膜黑素细胞肿瘤中的表达
Am J Vet Res. 2009 Oct;70(10):1284-90. doi: 10.2460/ajvr.70.10.1284.
10
Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.蛋白激酶A调节亚基1α在色素性上皮样黑素细胞瘤中表达缺失,但在黑色素瘤或其他黑素细胞性病变中无此现象。
Am J Surg Pathol. 2007 Nov;31(11):1764-75. doi: 10.1097/PAS.0b013e318057faa7.

本文引用的文献

1
Programmed Cell Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Equine Melanocytic Tumors.程序性细胞死亡配体1(PD-L1)在马黑素细胞肿瘤中的免疫组织化学表达
Animals (Basel). 2023 Dec 22;14(1):48. doi: 10.3390/ani14010048.
2
E-Cadherin Immunostaining in Equine Melanocytic Tumors.马黑素细胞肿瘤中的E-钙黏蛋白免疫染色
Animals (Basel). 2023 Jul 6;13(13):2216. doi: 10.3390/ani13132216.
3
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.表型转换与黑素瘤微环境;对免疫治疗和耐药性的影响。
Int J Mol Sci. 2023 Jan 13;24(2):1601. doi: 10.3390/ijms24021601.
4
Equine Melanocytic Tumors: A Narrative Review.马黑素细胞瘤:一篇叙述性综述。
Animals (Basel). 2023 Jan 10;13(2):247. doi: 10.3390/ani13020247.
5
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities.环氧化酶-2(COX-2)作为抗癌药物靶点:具有抗癌和COX-2抑制潜力的新型合成支架综述
Pharmaceuticals (Basel). 2022 Nov 26;15(12):1471. doi: 10.3390/ph15121471.
6
Interventions for treatment of cutaneous melanoma in horses: a structured literature review.干预措施治疗马皮肤黑色素瘤的:一个结构化的文献综述。
Vet Res Commun. 2023 Jun;47(2):347-360. doi: 10.1007/s11259-022-10023-8. Epub 2022 Nov 4.
7
Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma.用于治疗黑色素瘤的药物治疗选择及新型给药系统
Mol Pharm. 2022 Dec 5;19(12):4487-4505. doi: 10.1021/acs.molpharmaceut.2c00775. Epub 2022 Oct 28.
8
Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.抗 PD-L1 治疗的犬恶性黑色素瘤患者血清生物标志物的探索及 COX-2 抑制联合治疗的潜力。
Sci Rep. 2022 Jun 3;12(1):9265. doi: 10.1038/s41598-022-13484-8.
9
The "Inside" Story on Tumor-Expressed PD-L1.肿瘤表达 PD-L1 的“内幕”故事。
Cancer Res. 2022 Jun 6;82(11):2069-2071. doi: 10.1158/0008-5472.CAN-22-1060.
10
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research.犬黑色素瘤免疫学与免疫疗法:转化研究的相关性
Front Vet Sci. 2022 Feb 11;9:803093. doi: 10.3389/fvets.2022.803093. eCollection 2022.